Necitumumab Intravenous and Suclear
Determining the interaction of Necitumumab Intravenous and Suclear and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: necitumumab
Brand name: Portrazza
Synonyms: Necitumumab
Generic Name: polyethylene glycol 3350 with electrolytes
Brand name: Suclear, Colyte with Flavor Packs, GaviLyte-C, GoLYTELY, MoviPrep, NuLYTELY Orange, NuLYTELY with Flavor Packs, PEG-3350 with Electolytes, Plenvu, TriLyte with Flavor Packs, NuLYTELY, TriLyte
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Necitumumab Intravenous-Sucralfate
- Necitumumab Intravenous-Sucralfate Oral Suspension
- Necitumumab Intravenous-Sucralfate Suspension
- Necitumumab Intravenous-Sucralfate Tablet
- Necitumumab Intravenous-Sucralfate Tablets
- Necitumumab Intravenous-Sucrets 4-Hour Cough Drops
- Suclear-Necon
- Suclear-Necon 0.5/35
- Suclear-Necon 1/35
- Suclear-Necon 1/50
- Suclear-Necon 1/50 (28)
- Suclear-Necon 7/7/7